Navignostics was founded in 2022 as a spin-off from the University of Zurich Bodenmiller Lab. Their laboratory and headquarters are located in Horgen, Switzerland, where a growing team of scientists, lab technicians, software developers, and business experts work together to solve partners' problems by fighting cancer through enabling personalized treatments.

They analyze tumor samples and determine the best way to target each cancerous growth, helping clinicians find the right therapy for each patient and aiding researchers and drug developers in identifying the right patient groups and developing new drugs. Their approach combines highly multiplex protein imaging with advanced data analytics using spatial single-cell proteomics, validated through over a decade of translational and clinical research.

The mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey. Navignostics accelerates cancer drug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development, positioning them as a leading provider of precision cancer diagnostics services to pharma and biotech partners.

Navignostics AG is headquartered at Tödistrasse 46a, 8810 Horgen, Zurich, Switzerland.

Phone: +41 44 224 09 70

The company's LinkedIn page is https://www.linkedin.com/company/navignostics/ where they have 2,774 followers and provide updates, job postings, and company news.

The careers and job postings are accessible via LinkedIn: https://www.linkedin.com/company/navignostics/ or the careers section on their website (https://www.navignostics.com/about-us/#careers) though direct job listings were not accessible via crawl.